CELLPROTHERA Trademark

Trademark Overview


On Friday, July 31, 2009, a trademark application was filed for CELLPROTHERA with the United States Patent and Trademark Office. The USPTO has given the CELLPROTHERA trademark a serial number of 79076423. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, August 1, 2019. This trademark is owned by CELLPROTHERA. The CELLPROTHERA trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Biological preparations for cell cultures; cell culture media, namely, culture media for endothelial and myocardiac cells; culture media for cell growth for medical biotechnology, namely,culture media for growing and regenerating endothelial and myocardiac cells; biological reagents for molecular biology; chemical reagents for medical use for biological processes; carriers of culture media for medical use, namely, Iscove's modified Dulbecco's medium, used for rapidly proliferating high density cell cultures; cellular function activating agents, namely,cell growth factors, hematopoietic factors, serums, namely, human and animal serums for cell culture; antibodies, namely, monoclonal antibodies for detection and treatment of pathologies; all these products being for medical use

Medical care and treatment; medical services for cell sampling and isolation, namely, leukapheresis medical treatment services; services for medical analysis relating to treating individuals, namely, behavior analysis for medical purposes; therapeutic treatment, namely, cell therapy for regenerative medicine

Medical apparatus and instruments, namely, intravascular cell reinjection catheters; apparatus for human cell culture, namely, medical device for providing human cell culture diagnosis and treatment; cell analyzers for medical treatment and diagnostic use; medical device for production of human cell grafts, namely, medical device allowing in vitro stem cell expansion for therapeutic use; instruments for cell culture, namely, medical instruments used for cell culture diagnosis and treatment; medical device for human cell selection, namely, medical device for human cell immune selection used for diagnosis and treatment

Research and development of new products in the field of biotechnology; services for scientific analysis for medical purposes, namely, medical research laboratory services; development of new products for medical research for third parties
cellprothera

General Information


Serial Number79076423
Word MarkCELLPROTHERA
Filing DateFriday, July 31, 2009
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, August 1, 2019
Registration Number3980163
Registration DateTuesday, June 21, 2011
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 5, 2011

Trademark Statements


Description of MarkThe mark consists of the wording "CellProthera" in a stylized font with the letter "o" represented by a solid circle.
Goods and ServicesBiological preparations for cell cultures; cell culture media, namely, culture media for endothelial and myocardiac cells; culture media for cell growth for medical biotechnology, namely,culture media for growing and regenerating endothelial and myocardiac cells; biological reagents for molecular biology; chemical reagents for medical use for biological processes; carriers of culture media for medical use, namely, Iscove's modified Dulbecco's medium, used for rapidly proliferating high density cell cultures; cellular function activating agents, namely,cell growth factors, hematopoietic factors, serums, namely, human and animal serums for cell culture; antibodies, namely, monoclonal antibodies for detection and treatment of pathologies; all these products being for medical use
Pseudo MarkCELL PROTHERA
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical care and treatment; medical services for cell sampling and isolation, namely, leukapheresis medical treatment services; services for medical analysis relating to treating individuals, namely, behavior analysis for medical purposes; therapeutic treatment, namely, cell therapy for regenerative medicine
Goods and ServicesMedical apparatus and instruments, namely, intravascular cell reinjection catheters; apparatus for human cell culture, namely, medical device for providing human cell culture diagnosis and treatment; cell analyzers for medical treatment and diagnostic use; medical device for production of human cell grafts, namely, medical device allowing in vitro stem cell expansion for therapeutic use; instruments for cell culture, namely, medical instruments used for cell culture diagnosis and treatment; medical device for human cell selection, namely, medical device for human cell immune selection used for diagnosis and treatment
Goods and ServicesResearch and development of new products in the field of biotechnology; services for scientific analysis for medical purposes, namely, medical research laboratory services; development of new products for medical research for third parties

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 26, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 26, 2018
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 26, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 26, 2018
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCELLPROTHERA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR

Party NameCELLPROTHERA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR

Party NameCELLPROTHERA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Monday, May 30, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, October 29, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Saturday, September 4, 2021NOTIFICATION PROCESSED BY IB
Saturday, August 29, 2020REFUSAL PROCESSED BY IB
Friday, February 21, 2020NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, February 21, 2020DEATH OF INTERNATIONAL REGISTRATION
Thursday, August 22, 2019CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, August 1, 2019NEW REPRESENTATIVE AT IB RECEIVED
Friday, December 14, 2018TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, September 27, 2018TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, September 27, 2018INVALIDATION PROCESSED
Wednesday, September 26, 2018TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, January 26, 2018CANCELLED SECTION 71
Tuesday, May 14, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, November 17, 2011FINAL DISPOSITION NOTICE SENT TO IB
Thursday, November 17, 2011FINAL DISPOSITION PROCESSED
Wednesday, September 21, 2011FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 21, 2011REGISTERED-PRINCIPAL REGISTER
Saturday, June 11, 2011NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, May 25, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 25, 2011NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, April 5, 2011PUBLISHED FOR OPPOSITION
Thursday, March 17, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, March 17, 2011NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 16, 2011NOTICE OF PUBLICATION
Wednesday, March 2, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 2, 2011ASSIGNED TO LIE
Wednesday, February 2, 2011ASSIGNED TO LIE
Monday, January 31, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 24, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 24, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 24, 2011TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, August 11, 2010FINAL REFUSAL MAILED
Tuesday, August 10, 2010FINAL REFUSAL WRITTEN
Tuesday, August 10, 2010DATA MODIFICATION COMPLETED
Tuesday, July 20, 2010AMENDMENT FROM APPLICANT ENTERED
Tuesday, July 20, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 17, 2010ASSIGNED TO LIE
Tuesday, July 6, 2010PAPER RECEIVED
Friday, January 29, 2010REFUSAL PROCESSED BY IB
Wednesday, January 6, 2010NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, January 6, 2010REFUSAL PROCESSED BY MPU
Wednesday, January 6, 2010NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, January 5, 2010NON-FINAL ACTION WRITTEN
Saturday, January 2, 2010APPLICATION FILING RECEIPT MAILED
Tuesday, December 29, 2009ASSIGNED TO EXAMINER
Tuesday, December 29, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 24, 2009SN ASSIGNED FOR SECT 66A APPL FROM IB